Related Experiment Video
Updated: Apr 1, 2026
08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
8.1K
In Vitro Macrophage Phagocytosis Assay
Magda R Hamczyk1, Ricardo Villa-Bellosta1, Vicente Andrés2
1Laboratory of Molecular and Genetic Cardiovascular Pathophysiology, Vascular Biology Program, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Methods in Molecular Biology (Clifton, N.J.)
|October 9, 2015
Summary
Macrophages clear cellular debris in atherosclerosis, but impaired phagocytosis in late stages promotes plaque rupture. Understanding macrophage function offers new therapeutic targets for heart attack and stroke.
Area of Science:
- Immunology
- Cardiovascular Biology
- Cell Biology
Background:
- Macrophages are crucial in atherosclerosis, clearing apoptotic cells and debris.
- Reduced macrophage phagocytosis in advanced atherosclerosis exacerbates inflammation and plaque instability.
- This impairment may stem from an imbalance between M1 and M2 macrophage subsets.
Purpose of the Study:
- To investigate the role of macrophage phagocytosis in atherosclerosis.
- To understand the mechanisms regulating macrophage phagocytic activity.
- To identify potential therapeutic targets for atherosclerosis-related ischemic events.
Main Methods:
- Establishing primary mouse macrophage cultures.
- Polarizing macrophages into M1 and M2 states.
- In vitro assessment of macrophage phagocytosis of opsonized erythrocytes.
Main Results:
- The study provides a protocol for macrophage culture and polarization.
- Methods for studying phagocytosis of IgG- or IgM/C3-opsonized erythrocytes are detailed.
- This facilitates research into macrophage dysfunction in atherosclerosis.
Conclusions:
- Understanding macrophage phagocytosis regulation is key to developing atherosclerosis therapies.
- Defective phagocytosis contributes to necrotic core formation and inflammation.
- Targeting macrophage function may prevent myocardial infarction and stroke.
